Since revealing her plaque psoriasis diagnosis in 2015, La La Anthony has become a powerful voice for those living with the ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

according to the analysis of patients with plaque psoriasis. “We typically don’t think about putting cream on the scalp,” she added, but additional research looking at this PAD-formulated ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Involvement of problematic areas -- scalp, intertriginous sites ... for inverse psoriasis and tapinarof for thicker plaque psoriasis." Cheng said insurance considerations often come into play ...

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...

Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO ... at least moderate severity affecting special areas (e.g., scalp, genital, and/or hands and feet) with overall IGA score ...

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 ...

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis ... based on the PDUFA for the treatment of scalp and body psoriasis, the potential for clinical results for ZORYVE ...